ArticleCanadian journal of public health = Revue canadienne de sante publique2026
Temporal trends in emergency department opioid prescribing and related harms in Alberta, Canada: A population-based cohort study.
Article in Canadian journal of public health = Revue canadienne de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesEmergency department (ED) opioid prescribing has been implicated in the opioid crisis, yet Canadian ED prescribing patterns and related harms remain poorly described. We analyzed trends in ED opioid prescribing and adverse outcomes in Alberta, Canada, from 2010 to -2020.
methodsWe conducted a population-based retrospective cohort study using linked administrative health data for all Alberta ED visits, 2010-2020. We included discharged patients ≥ 12 years and excluded those with long-term opioid use (LTU) or possible opioid use disorder (OUD; prior opioid-related ED visit, hospitalization, or opioid agonist therapy). We measured opioid dispensations within three 3 days of discharge and adverse events (LTU and possible OUD) within 12 months. Interrupted time series assessed associations between opioid prescribing guidelines (United States (US): March 2016; Canada: May 2017), prescribing rates, and adverse events.
resultsAmong 12.1 million ED visits, opioids were prescribed in 7.4% overall, rising from 6.8% (2010) to 8.2% (2016), then declining to 7.1% (2020). Of those prescribed opioids, 3.6% developed LTU and 0.12% possible OUD within one 1 year. LTU incidence decreased over time and appeared uncorrelated with prescribing rates, while possible OUD increased steadily. The US guideline release was associated with reduced prescribing; Canadian guidelines had no impact.
conclusionED opioid prescribing in Alberta peaked in 2016 before declining. Prescribing rates did not correlate with adverse outcomes (LTU or possible OUD). This decoupling of exposure from outcomes suggests a limited role for ED prescribing in the opioid crisis.
Indexed as
Identifiers
41870872What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.